AVAVA SR-1 Wrinkles and BPL Study (NCT04925921) | Clinical Trial Compass
CompletedNot Applicable
AVAVA SR-1 Wrinkles and BPL Study
United States20 participantsStarted 2021-05-10
Plain-language summary
This study is being conducted to evaluate the safety and efficacy of a laser called the SR-1 Skin Treatment System, or SR-1 Laser, for the treatment of wrinkles and pigmented spots. Participants will be treated with the SR-1 Laser 3 or 4 times with each treatment spaced 4-6 weeks apart. The improvement in wrinkles and pigmented spots will be evaluated 1 and 3 months after the final treatment.
Who can participate
Age range22 Years β 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Wrinkles on both sides of the face (e.g., peri-oral, peri-orbital, and cheek) scored 4-9 on the Fitzpatrick Wrinkle and Elastosis Scale
β. Willingness to have both sides of the face exposed to the SR-1 Laser.
β. Willingness to have digital photographs taken of their face and agreement with use of photographs, with their identity protected, for presentation, educational, or marketing purposes.
β. Willingness to comply with the following during the study, including the follow-up period:
β. maintain consistent skin care regimen on treated areas
β. cover treated areas or have very limited sun exposure and use a provided sunscreen as directed by the Investigator
β. refrain from using systemic corticosteroids
β. refrain from using systemic or topical skin-lightening medications or retinoids
Exclusion criteria
β. Skin pathology or condition, or medication use that could interfere with evaluation of the study procedure, e.g.,
β. Isotretinoin use within previous 6 months
β. Surgical treatment in the target areas within previous 6 months
β. Active vitiligo, psoriasis, or eczema, or history of these in the treatment area
β. Injection of botulinum toxin in the treatment areas within the previous 3 months.
β. Facial cosmetic procedures in the target areas within previous 6 months (e.g., laser or other energy-based device treatment, microdermabrasion, microneedling, chemical peel, injection of dermal filler).
β. Current smoker or history of smoking greater than 0.5 pack/day in past 5 years.
β. Excessive sun exposure in the previous month, or unable or unlikely to refrain from tanning or excessive sun exposure during the study.